Evotec SE (EVO) Gross Profit (2009 - 2025)

Evotec SE (EVO) reported Gross Profit of $91377.4 for Q4 2025, up 85.49% on a YoY basis from $49262.2 in Q4 2024, and up 100.13% sequentially from -$72.5 million in Q3 2025.

Evotec SE (EVO) Gross Profit (2009 - 2025) Analysis & Trends

Evotec SE (EVO) has 9 years of Gross Profit data on file, last reported at $91377.4 in Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 85.49% year-over-year to $91377.4; the trailing twelve-month figure through Dec 2025 stood at -$72.3 million (down 28095.29% YoY), and the FY2025 full-year result was $132.93, up 8.27% from the prior year.
  • Gross Profit climbed to $91377.4 in Q4 2025, from -$72.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $147816.9 in Q4 2023 to a low of -$72.5 million in Q3 2025.
  • A 5-year average of -$4.8 million and a median of $41173.8 in 2023 frame the typical range for Gross Profit.
  • Peak annual rise in Gross Profit reached 85.49% in 2025, while the deepest fall reached 361085.75% in 2025.
  • Tracing EVO's Gross Profit over 5 years: stood at $113789.6 in 2021, then fell by 17.86% to $93463.8 in 2022, then surged by 58.15% to $147816.9 in 2023, then plunged by 66.67% to $49262.2 in 2024, then surged by 85.49% to $91377.4 in 2025.
  • Business Quant data shows EVO's Gross Profit at $91377.4 in Q4 2025, -$72.5 million in Q3 2025, and $49262.2 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Evotec SE 351.60 Mn 351.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 91,377.42
Dec 31, 2025 91,377.42
Sep 30, 2025 -72.48 Mn
Sep 30, 2025 -72.48 Mn
Dec 31, 2024 49,262.25
Dec 31, 2024 49,262.25
Sep 30, 2024 20,078.75
Sep 30, 2024 20,078.75
Dec 31, 2023 147,816.93
Dec 31, 2023 147,816.93
Sep 30, 2023 41,173.76
Sep 30, 2023 41,173.76
Jun 30, 2023 57,969.98
Jun 30, 2023 57,969.98
Dec 31, 2022 93,463.84
Dec 31, 2022 93,463.84
Sep 30, 2022 28,655.16
Sep 30, 2022 28,655.16
Jun 30, 2022 32,966.72
Jun 30, 2022 32,966.72